Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.vaccine.2020.10.094 http://scihub22266oqcxt.onion/10.1016/j.vaccine.2020.10.094 33189428!7641879!33189428     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Vaccine 2021 ; 39 (6): 886-888 Nephropedia Template TP {{tp|p=33189428|t=2021. Duration of anti-SARS-CoV-2 antibodies much shorter in India |pdf=|usr=}}{{33189428}} gab.com Text Duration of anti-SARS-CoV-2 antibodies much shorter in India JO: Vaccine http://www.kidney.de/pget.php?&tw=1&pmid=33189428 #FOAvip Seroprevalence survey, for antibodies to SARS-CoV-2, of healthcare workers (HCW) working in three Government run hospitals in Mumbai was carried out in June 2020. Among the 801 HCWs tested, seroprevalence was 11.1%. Males (13.5% vs. 8.9% in females) and ancillary workers (18.5% vs 6.9% in doctors and nurses) were more likely to be seropositive. Sixty-two (7.74%) had been previously diagnosed with RT PCR test for SARS-CoV-2. Of these, 44 (71%) were seronegative. Upto 28 days after a positive PCR test, 90% of subjects were found to be seropositive. This reduced to less than half (38.5%) between 29 and 42 days. None of 28 infected HCWs who had the RT-PCR more than 50 days ago tested positive for antibodies. It seems likely that cellular immunity plays a larger role in defence against the illness. Twit Text FOAVip Duration of anti-SARS-CoV-2 antibodies much shorter in India ????Vaccine http://www.kidney.de/pget.php?&tw=1&pmid=33189428 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33189428 #FOAvip English Wikipedia <ref>{{Cite pmid|33189428}}</ref> Duration of anti-SARS-CoV-2 antibodies much shorter in India #MMPMID33189428 Kumar N; Bhartiya S; Singh T Vaccine 2021[Feb]; 39 (6): 886-888 PMID33189428show ga Seroprevalence survey, for antibodies to SARS-CoV-2, of healthcare workers (HCW) working in three Government run hospitals in Mumbai was carried out in June 2020. Among the 801 HCWs tested, seroprevalence was 11.1%. Males (13.5% vs. 8.9% in females) and ancillary workers (18.5% vs 6.9% in doctors and nurses) were more likely to be seropositive. Sixty-two (7.74%) had been previously diagnosed with RT PCR test for SARS-CoV-2. Of these, 44 (71%) were seronegative. Upto 28 days after a positive PCR test, 90% of subjects were found to be seropositive. This reduced to less than half (38.5%) between 29 and 42 days. None of 28 infected HCWs who had the RT-PCR more than 50 days ago tested positive for antibodies. It seems likely that cellular immunity plays a larger role in defence against the illness. |Adult[MESH] |Antibodies, Viral/*blood[MESH] |COVID-19 Nucleic Acid Testing[MESH] |COVID-19 Serological Testing[MESH] |COVID-19/blood/*epidemiology/*immunology[MESH] |Comorbidity[MESH] |Female[MESH] |Health Personnel/statistics & numerical data[MESH] |Hospitals[MESH] |Humans[MESH] |India/epidemiology[MESH] |Male[MESH] |Middle Aged[MESH] |Seroepidemiologic Studies[MESH] |Surveys and Questionnaires[MESH] |Time Factors[MESH]Duration of anti-SARS-CoV-2 antibodies much shorter in India (epmc).pdf DeepDyve Pubget Overpricing